HIV Drugs Market - Size, Share, Industry Trends, and Forecasts (2024 - 2031)

Report ID : CBI_1705 |  Category : Pharmaceuticals |  Format :  ms word  ms Excel  PDF

HIV Drugs Market Size, Growth, Analysis, Forecast 2024 To 2031

  1. Introduction
    1. Market Introduction
    2. Market Research Methodology
      1. Research Process
      2. Primary Research
      3. Secondary Research     
      4. Data Collection Technique      
      5. Data Sources      
    3. Market Estimation Methodology
      1. Limitations of the Study
    4. Product Picture of HIV Drugs
    5. Global HIV Drugs: Classification
    6. Geographic Scope 
    7. Years Considered for the Study 
    8. Research Methodology in Brief  
    9. Parent Market Overview
    10. Overall HIV Drugs Market Regional Demand
    11. Research Programs/Design       
    12. Market Breakdown and Data Triangulation Approach        
    13. Data Source
    14. Secondary Sources
    15. Primary Sources   
    16. Primary Interviews
    17. Average Primary Breakdown Ratio      
  2. Market Dynamics
    1. Drivers
      1. Drivers
    2. Restraints
      1. Restraints
    3. Opportunity
      1. Impact forces on market dynamics   
      2. Impact forces during the forecast years     
    4. Industry Value Chain
      1. Upstream analysis        
      2. Downstream analysis   
      3. Distribution Channel     
      4. Direct Channel    
      5. Indirect Channel 
    5. Potential Customers
    6. Manufacturing/Operational Cost Analysis
    7. Key Material Landscape
    8. Porter’s Analysis
      1. Supplier Power   
      2. Buyer Power
      3. Substitution Threat       
      4. Threat from New Entry 
      5. Competitive Rivalry      
    9. PESTEL Analysis 
      1. Political Factors  
      2. Economic Factor 
      3. Social Factors     
      4. Technological Factor     
      5. Environmental Factors  
      6. Legal Factor       
  3. Global HIV Drugs Market Segmentation, Revenue (USD Million), (2024-2031)
    1. By Drug Class
      1. Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
      2. Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
      3. Protease Inhibitors (PIs)
      4. Integrase Inhibitors
      5. Combination Medicines
      6. Others
    2. By Derivative
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
  4. By Global HIV Drugs Market Overview, By Region
    1.  North America HIV Drugs Market Revenue (USD Million), By Countries, (2024-2031)
      1.  US
        1. By Drug Class
        2. By Distribution Channel
      2. Canada
      3. Mexico
    2. Europe HIV Drugs Market Revenue (USD Million), By Countries, (2024-2031)
      1. Germany
      2. France        
      3. UK
      4. Spain
      5. Russia
      6. Italy
      7. BENELUX
    3. Asia Pacific HIV Drugs Market Revenue (USD Million), By Countries, (2024-2031)
      1.  China
      2.  Japan
      3.  Australia
      4.  South Korea
      5.  India
      6.  ASEAN
    4. Latin America HIV Drugs Market Revenue (USD Million), By Countries, (2024-2031)
      1.  Brazil
      2.  Argentina
      3.  Chile
    5. Middle East and Africa HIV Drugs Market Revenue (USD Million), By Countries, (2024-2031)
      1. GCC
      2. Turkey        
      3. South Africa
  5. Global HIV Drugs Market Revenue: Competitive Analysis, 2023
    1. Key strategies By players
    2. Revenue (USD Million) and Market Share (%), By Manufacturers, 2023
    3. Player Positioning By Market Players, 2023
  6. Competitive Analysis
    1. ViiV Healthcare (U.S.)
      1. Business Overview
      2. Business Financials (USD Million)
      3. Product Category, Type, and Specification     
      4. Main Business/Business Overview
      5. Geographical Analysis
      6. Recent Development
      7. Swot Analysis
    2. Gilead Sciences, Inc. (U.S.)
    3. GlaxoSmithKline plc (U.K.)
    4. Merck & Co., Inc. (Germany)
    5. Bristol-Myers Squibb Company (U.S.)
    6. Janssen Pharmaceuticals (Belgium)
    7. Boehringer Ingelheim International GmbH (Germany)
    8. AbbVie Inc. (U.S.)
    9. Hetero Drugs (India)
    10. Theratechnologies Inc. (Canada)

Market Research Findings & Conclusion 

Disclaimer